Table 1.

Mean changes in cortical and VTA EEG and EMG total powers induced by intravenous nicotine, nicotinePM, and saline in drug-naive conditions and after drug experiencea

GroupImmediate effect (5–30 s)Long-term effect (30–300 s)
CortexVTAEMGCortexVTAEMG
Nicotine (naive)32.47 ± 2.9926.23 ± 2.118.38 ± 0.3036.00 ± 2.5027.43 ± 2.138.11 ± 0.34
Nicotine (Nicotine)30.39 ± 2.2524.51 ± 1.997.90 ± 0.2729.85 ± 1.66*23.00 ± 1.767.65 ± 0.33
NicotinePM (naive)38.85 ± 2.2831.06 ± 4.236.58 ± 0.1174.94 ± 3.1468.02 ± 5.124.94 ± 0.51
NicotinePM (NicotinePM)63.48 ± 3.86***51.96 ± 5.08***5.87 ± 0.09***93.25 ± 4.42***84.43 ± 4.25*4.15 ± 0.37
NicotinePM (Nicotine)36.04 ± 1.43††32.71 ± 2.04††7.11 ± 0.19††59.06 ± 6.38*,††48.90 ± 4.98*,††6.99 ± 0.49*,†††
Saline (naive)53.68 ± 3.1446.16 ± 4.175.68 ± 0.2587.63 ± 3.1880.10 ± 3.524.64 ± 0.25
Saline (NIC)41.99 ± 5.0035.25 ± 4.126.73 ± 0.28*80.73 ± 4.1472.17 ± 4.094.71 ± 0.26
  • aData are grouped depending upon the drug tested (nicotine, nicotinePM, or saline) and previous drug experience: (naive), No experience, (Nicotine) and (NicotinePM), 2 d of previous nicotine or nicotinePM treatment, respectively. EEG total power is represented in percentages versus preinjection baseline (100%). Because of large-magnitude changes, EMG total power is shown as ln(%).

  • Significant differences in each drug group (saline, nicotine, and nicotinePM) versus “naive” conditions (*p < 0.05; ***p < 0.001; Student's t test). Significant differences between the effects of nicotinePM after previous nicotinePM and nicotine experience (p < 0.05; ††p < 0.01; †††p < 0.001).